Tuesday, July 8th 2008 at the BioPark, Hertfordshire

This meeting is designed to discuss the advances made in ELISPOT technology including the range of cytokines that can be measured, as well as discussions on assay development and applications to both basic and clinical research.

ELISPOT technology” will cover all aspects of the assay development from initial cell stimulation to analyzing spot formation. Dr Sefina Arif (Meeting Chair)

Speakers include:Professor Paul Lehmann (Professor of Pathology at Case Western Reserve University, USA), Professor Peter Van der Meide (Associate Professor Utrecht University and U-CyTech biosciences, The Netherlands), Professor Ajit Lalvani (Head, Tuberculosis Immunology Group, National Heart and Lung Institute, UK), Dr Werner Freber (CEO and founder of BIO-SYS GmbH, Germany ), Assoc. Professor Niklas Ahlborg (Mabtech AB, Sweden), Dr Roberto Mallone (Hopital Saint Vincent de Paul, France) and Dr Huriya Beyan (Queen Mary, University of London, UK)

The deadline for abstract submissions is March 10th 2008
Abstract guidelines can be found at
http://www.euroscicon.com/absguidlines.html

The deadline for early (reduced rate) registration is April 20th 2008

For more information and to book a place please go to http://www.regonline.co.uk/elispot08

For General enquiries email: enquiries@euroscicon.com, website: www.euroscicon.com

We seek CPD accreditation from the IBMS for all our meetings